Imperial College London
Dr Sophie Coronini-Cronberg

Dr Sophie Coronini-Cronberg

Faculty of Medicine, School of Public Health

Honorary Senior Lecturer
 
 
 
//

Contact

 

s.coronini-cronberg

 
 
//

Location

 

Chelsea and Westminster HospitalChelsea and Westminster Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Coronini-Cronberg:2011:10.1258/shorts.2011.011089,
author = {Coronini-Cronberg, S and Heffernan, C and Robinson, M},
doi = {10.1258/shorts.2011.011089},
journal = {JRSM short reports},
title = {Effective smoking cessation interventions for COPD patients: a review of the evidence},
url = {http://dx.doi.org/10.1258/shorts.2011.011089},
volume = {2},
year = {2011}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Objectives To review the effectiveness of smoking cessationinterventions offered to chronic obstructive pulmonary disease (COPD)patients, and identify barriers to quitting experienced by them, so that amore effective service can be developed for this group.Design A rapid systematic literature review comprising computerizedsearches of electronic databases, hand searches and snowballing wereused to identify both published and grey literature.Setting A review of studies undertaken in north-western Europe(defined as: United Kingdom, Ireland, France, Germany, Benelux andNordic countries).Participants COPD patients participating in studies looking at theeffectiveness of smoking cessation interventions in this patient group, orexploring the barriers to quitting experienced by these patients.Method Quantitative and qualitative papers were selected according topre-specified inclusion and exclusion criteria, critically appraised, andquantitative papers scored against the NICE Levels of Evidencestandardized hierarchy.Main outcome measure Percentages of successful quitters andlength of quit, assessed by self-report or biochemical analysis. Amongqualitative studies, identified barriers to smoking cessation had to beexplored.Results Three qualitative and 13 quantitative papers were finallyselected. Effective interventions and barriers to smoking cessation wereidentified. Pharmacological support with Buproprion combined withcounselling was significantly more efficacious in achieving prolongedabstinence than a placebo by 18.9% (95% CI 3.6–26.4%). Annualspirometry with a brief smoking cessation intervention, followed by apersonal letter froma doctor, had a significantly higher ≥1 year abstinence rate at three years among COPD patient smokers, compared to smokerswith normal lung function (P < 0.001; z = 3.93). Identified barriers tocessation included: patient misinformation, levels of motivation, healthbeliefs, and poor communication with health professionals.Conclusion D
AU  - Coronini-Cronberg,S
AU  - Heffernan,C
AU  - Robinson,M
DO  - 10.1258/shorts.2011.011089
PY  - 2011///
TI  - Effective smoking cessation interventions for COPD patients: a review of the evidence
T2  - JRSM short reports
UR  - http://dx.doi.org/10.1258/shorts.2011.011089
VL  - 2
ER  -
Download